Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: RARE DISEASE COMPANY COALITION, RARE DISEASE COMPANY COALITION
Client-Reported Lobbying Expenses
$550K
34 filings
Firm Income Reported for This Client
$1.4M
Not substituted for client expenses
Summary
RARE DISEASE COMPANY COALITION is an organization, based in DC. Its political footprint includes $550K in client-reported lobbying expenses, $1.4 million in lobbying-firm income reported for this client. Lobbying activity focuses on Pharmacy, Health Issues, Trade (domestic/foreign), Taxation/Internal Revenue Code. Political activity spans from 2021 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Activity data: Senate LDA